RT @Yuz6Yusof: Is there a need to routinely monitor #ANA in patients treated on #TNF inhibitors? The juryð¨ââï¸is
Tweet Content
Is there a need to routinely monitor #ANA in patients treated on #TNF inhibitors? The jury👨⚖️is still out. Of N=211, Dr Oliveira reported 75.4% had seroconversion at median 31mths of TNFi therapy. Only 2/211 (0.9%) developed SLE (mild symptoms) #EULAR2021 #POS0204 @RheumNow https://t.co/UrFucJ9xnJ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off